PRO MEDICUS LIMITED — Director's Dealing 2020

Mar 17, 2020

Appendix 3Y

Listing Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity	Pro Medicus Limited
ABN	25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Anthony Barry HALL
Date of last notice	6 September 2019

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Ordinary fully paid shares in Pro MedicusLimited held by Anthony Barry HALL
Date of change	12 March 202017 March 2020
No. of securities held prior to change	28,067,500 ordinary shares consisting off:-•27,200,000ordinarysharesheldunder Anthony Barry HALL•867,500 ordinary shares held underAkay Superannuation Fund
Class	Ordinary shares
Number acquired	12March 2020 –35,000 ordinary shares17March 2020 –6,500 ordinary sharesAllpurchased by ResearchCorporation Pty Ltdas trustee for the Anthony Hall FamilyTrust

+ See chapter 19 for defined terms.

Number disposedValue/Consideration	Nil1,000 ordinary shares @ $17.0231per share
Note: If consideration is non-cash, provide details and estimated valuation	34,000 ordinary shares @ $17.355 per share6,500 ordinary shares @ $15.5562 per share
No. of securities held after change	28,109,000 ordinary shares consisting off:-•27,200,000ordinarysharesheldunder Anthony Barry HALL•867,500 ordinary shares held underAkay Superannuation Fund•41,500 ordinary shares held underResearch Corporation Pty Ltd astrustee for the Anthony Hall FamilyTrust
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On market trade

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

+ See chapter 19 for defined terms.

Part 3 – +Closed period

Were the interests in the securities or contracts detailed	No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the	N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was	N/A
this provided?

For and on behalf of Pro Medicus Limited

Clayton Hatch Company Secretary 18 March 2020

• See chapter 19 for defined terms.